|
Alere Inc. is a global diagnostic device and service provider. The company was founded in 2001 and is headquartered in Waltham, Massachusetts. As of March 2014, the company has a market capitalization of $3 billion with an enterprise value of $6.46 billion.〔 The company was formerly known as Inverness Medical Innovation, Inc. and changed its name to Alere Inc. in 2010.〔 In 2009, Alere won two awards in the 16th Annual National Health Information program, which recognizes the U.S.’s best consumer health information programs and materials. ==History== The company was initially set up in 1991 by Ron Zwanziger. Its original name was SelfCare, which became public in 1996. The company changed its name from SelfCare to Inverness Medical Technology (IMT) in 2000. One year later, it sold its diabetes business to Johnson & Johnson. The company subsequently expanded its business by acquiring many companies, including Wampole Laboratories, Ostex International, Binax, Biosite, Standard Diagnostics, Axis-Shield, etc. In 2007, Alere entered into a joint venture, named Swiss Precision Diagnostics, with Procter & Gamble for the sales and marketing of its consumer diagnostics products. In 2010, the company changed its name to Alere and began trading under the ticker (ALR ) in NYSE. In 2013, the company completed the acquisition of Epocal, Inc. In early 2015, Alere divested its Alere Health management activities to Optum. In July 2014 Ron Zwanziger resigned as CEO and COO Namal Nawana took over as interim CEO. In September 2014, Zwanziger offered to take the company private for $3.82 billion.〔(【引用サイトリンク】url=http://www.reuters.com/article/2014/09/15/us-alere-m-a-zwanziger-idUSKBN0HA1JZ20140915 )〕 In October 2014, the Board of Directors voted and instated Namal Nawana as the permanent CEO of Alere, Inc. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Alere」の詳細全文を読む スポンサード リンク
|